UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Penumbra
PEN
$12.8B
| $3.24M | ﹤0.01% |
19,706
+17,728
| +896% | +$2.82M |
|
3052
Global X Internet of Things ETF
SNSR
$223M
| $3.23M | ﹤0.01% |
136,958
+23,497
| +21% | +$522K |
|
3053
Emergent Biosolutions
EBS
$248M
| $3.23M | ﹤0.01% |
59,833
-53,744
| -47% | -$2.91M |
|
3054
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$395M
| $3.23M | ﹤0.01% |
56,614
-91,179
| -62% | -$4.97M |
|
3055
M/I Homes
MHO
$3.84B
| $3.23M | ﹤0.01% |
81,991
-26,262
| -24% | -$1.1M |
|
3056
Hackett Group
HCKT
$287M
| $3.22M | ﹤0.01% |
199,595
+180,814
| +963% | +$2.87M |
|
3057
CALL
Live Nation Entertainment
LYV
$42.1B
| $3.22M | ﹤0.01% |
+45,000
| New | +$3.05M |
|
3058
Aaon
AAON
$7.77B
| $3.21M | ﹤0.01% |
97,622
+34,386
| +54% | +$1.11M |
|
3059
Goldman Sachs Hedge Industry VIP ETF
GVIP
$578M
| $3.2M | ﹤0.01% |
50,489
-8,552
| -14% | -$506K |
|
3060
Halozyme
HALO
$12.2B
| $3.2M | ﹤0.01% |
180,482
-35,637
| -16% | -$617K |
|
3061
State Street SPDR S&P International Small Cap ETF
GWX
$913M
| $3.2M | ﹤0.01% |
100,393
+5,525
| +6% | +$170K |
|
3062
Progress Software
PRGS
$1.76B
| $3.2M | ﹤0.01% |
76,927
+26,715
| +53% | +$1.09M |
|
3063
Simply Good Foods
SMPL
$982M
| $3.19M | ﹤0.01% |
111,873
+16,411
| +17% | +$433K |
|
|
ONC
3064
BeOne Medicines Ltd
ONC
$39.4B
| $3.19M | ﹤0.01% |
19,249
-9,880
| -34% | -$1.64M |
|
3065
DaVita
DVA
$11.7B
| $3.18M | ﹤0.01% |
42,420
+24,150
| +132% | +$1.6M |
|
3066
Cemex
CX
$16.3B
| $3.18M | ﹤0.01% |
841,227
+328,130
| +64% | +$1.25M |
|
|
RETA
3067
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.18M | ﹤0.01% |
15,536
+9,581
| +161% | +$1.75M |
|
|
PRFT
3068
DELISTED
Perficient Inc
PRFT
| $3.17M | ﹤0.01% |
68,909
+26,074
| +61% | +$1.06M |
|
3069
Four Corners Property Trust
FCPT
$2.75B
| $3.17M | ﹤0.01% |
112,467
+38,519
| +52% | +$1.08M |
|
3070
Texas Capital Bancshares
TCBI
$4.32B
| $3.17M | ﹤0.01% |
55,834
-14,556
| -21% | -$830K |
|
3071
CALL
Steven Madden
SHOO
$3.55B
| $3.16M | ﹤0.01% |
+73,400
| New | +$2.96M |
|
|
3072
PUT
Steven Madden
SHOO
$3.55B
| $3.16M | ﹤0.01% |
+73,400
| New | +$2.96M |
|
|
AAT
3073
American Assets Trust
AAT
$1.4B
| $3.15M | ﹤0.01% |
68,679
+35,375
| +106% | +$1.65M |
|
3074
AerCap
AER
$23.8B
| $3.15M | ﹤0.01% |
51,280
+21,532
| +72% | +$1.27M |
|
3075
Corcept Therapeutics
CORT
$12B
| $3.15M | ﹤0.01% |
260,417
+106,234
| +69% | +$1.48M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.